Tone mix
Week by week 51 weeks
Share of Kura Oncology, Inc.'s 148 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Mar 30, 2026 · tone +100Kura Oncology, Inc. (NASDAQ:KURA) Receives Average Recommendation of "Moderate Buy" from Analysts+94
- Week of Apr 13, 2026 · tone +99Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib+89
- Week of Apr 20, 2026 · tone +99Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML+77
- Week of Dec 15, 2025 · tone +100Kura Oncology (KURA) Gains Momentum as Barclays Sees Significant Potential in Ziftomenib Approval+75
- Week of Jun 8, 2026 · tone +100Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML+54
- Week of May 4, 2026 · tone 0Kura Oncology to Report First Quarter 2026 Financial Results-50
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Kura Oncology, Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 11 | +9 |
| Last 90 sessions | 47 | +35 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 14, 2026
2 headlines, average tone +49: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletKura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin InhibitorPositive
- www.rttnews.com · 1 outletCaspian Therapeutics, Kura Oncology Outline Development Path For Diabetes Candidate KO-7246Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Kura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin Inhibitor | www.themarketsdaily.com | 1 | Positive |
| Caspian Therapeutics, Kura Oncology Outline Development Path For Diabetes Candidate KO-7246 | www.rttnews.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCaspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in DiabetesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletCaspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian's Launch and KO-7246 Preclinical Data in DiabetesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian's Launch and KO-7246 Preclinical Data in Diabetes | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 2, 2026
4 headlines, average tone 0: 0 positive, 4 neutral and 0 negative. Showing all 4.
- www.manilatimes.net · 1 outletKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Neutral
- www.tickerreport.com · 1 outletKura Oncology (NASDAQ:KURA) COO Sells $39,431.00 in StockNeutral
- www.dailypolitical.com · 1 outletInsider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells $165,872.50 in StockNeutral
- www.tickerreport.com · 1 outletInsider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells $130,704.00 in StockNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | www.manilatimes.net | 1 | Neutral |
| Kura Oncology (NASDAQ:KURA) COO Sells $39,431.00 in Stock | www.tickerreport.com | 1 | Neutral |
| Insider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells $165,872.50 in Stock | www.dailypolitical.com | 1 | Neutral |
| Insider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells $130,704.00 in Stock | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, September 30, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletInsider Selling: Kura Oncology (NASDAQ:KURA) COO Sells 3,668 Shares of Company StockNeutral
- www.themarketsdaily.com · 1 outletKura Oncology (NASDAQ:KURA) Insider Sells $165,872.50 in StockNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Insider Selling: Kura Oncology (NASDAQ:KURA) COO Sells 3,668 Shares of Company Stock | www.themarketsdaily.com | 1 | Neutral |
| Kura Oncology (NASDAQ:KURA) Insider Sells $165,872.50 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Kura Oncology, Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.